The ECSEL Joint Undertaking Moore4Medical kicked off in June 2020 with the overarching objective to accelerate innovation in electronic medical devices. Moore4Medical is masterminded by prof. Ronald Dekker (Philips Research & ECTM) and sees important involvement and vast opportunities for TU Delft’s Microelectronics department.
The project addresses emerging medical applications and technologies that offer significant new opportunities for the Electronic Systems & Components (ECS) industry, including: bioelectronic medicines, organ-on-chip, drug adherence monitoring, smart ultrasound, radiation free interventions and continuous monitoring. The new technologies will help fighting the increasing cost of healthcare by reducing the need for hospitalisation, helping to develop personalized therapies, and realising intelligent point-of-care diagnostic tools.
Moore4Medical will bring together 66 selected companies, universities and institutes from 12 countries who will develop open technology platforms for these emerging fields to help them bridge “the Valley of Death” in shorter time and at lower cost. Open technology platforms used by multiple users for multiple applications with the prospect of medium-to-high volume markets are an attractive proposition for the European ECS industry. The combination of typical MedTech and Pharma applications with an ECS style platform approach will enhance the competitiveness for the emerging medical domains addressed in Moore4Medical. With value and IP moving from the technology level towards applications and solutions, defragmentation and open technology platforms will be key in acquiring and maintaining a premier position for Europe in the forefront of affordable healthcare.
TU Delft’s Microelectronics department leads two of the six workpackages represented in Moore4Medical: the Implanatable Devices workpackage, led by Dr. Vasiliki “Vasso” Giagka (BE & Fraunhofer IZM), and the Organ-on-Chip workpackage, led by Dr. Massimo “Max” Mastrangeli (ECTM). Both workpackages will see the interaction and contribution of many world-class industrial and academic players to develop respectively bioelectronic medicines and smart multi-well plate platforms, and will provide a rich opportunity to capitalize on and further expand the standing expertise of the BE and ECTM groups of the department.
For more information, see the project homepage.